A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 2,875 shares of ABBV stock, worth $576,466. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,875
Previous 2,864 0.38%
Holding current value
$576,466
Previous $491 Million 15.56%
% of portfolio
0.17%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $1,802 - $2,192
11 Added 0.38%
2,875 $568 Million
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $2,321 - $2,711
15 Added 0.53%
2,864 $491 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $216,236 - $246,381
1,353 Added 90.44%
2,849 $519 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $205,849 - $231,835
1,496 New
1,496 $232 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Atlantic Edge Private Wealth Management, LLC Portfolio

Follow Atlantic Edge Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Edge Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Edge Private Wealth Management, LLC with notifications on news.